These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 6186266)

  • 1. Functional and phenotypic analysis of isolated human Langerhans cells and indeterminate cells.
    Czernielewski JM; Schmitt D; Faure MR; Thivolet J
    Br J Dermatol; 1983 Feb; 108(2):129-38. PubMed ID: 6186266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of HLA-DR bearing Langerhans and epidermal indeterminate cells in the in vitro generation of alloreactive cytotoxic T cells in man.
    Faure M; Frappaz A; Schmitt D; Dezutter-Dambuyant C; Thivolet J
    Cell Immunol; 1984 Feb; 83(2):271-9. PubMed ID: 6229342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro mixed skin cell lymphocyte culture reaction (MSLR) in man: analysis of the epidermal cell and T cell subpopulations.
    Czernielewski J; Faure M; Schmitt D; Thivolet J
    Clin Exp Immunol; 1982 Nov; 50(2):426-33. PubMed ID: 6217936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies of epidermal antigen-presenting cells. The mixed skin lymphocyte reaction: an in vitro model for the generation of alloreactive cytotoxic T cells by human epidermal cells.
    Faure M; Schmitt D; Dezutter-Dambuyant C; Frappaz A; Gaucherand M; Thivolet J
    Br J Dermatol; 1984 Jul; 111 Suppl 27():11-7. PubMed ID: 6234919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of allogeneic T-cell activating ability and Langerhans cell markers in human epidermal cell cultures.
    Demidem A; Faure M; Dezutter-Dambuyant C; Thivolet J
    Clin Immunol Immunopathol; 1986 Mar; 38(3):319-26. PubMed ID: 2935342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human epidermal cell-induced generation of alloreactive cytotoxic T-lymphocyte responses against epidermal cells. Requirement for DR-positive Langerhans cells.
    Faure M; Dezutter-Dambuyant C; Schmitt D; Gaucherand M; Thivolet J
    Scand J Immunol; 1985 May; 21(5):441-6. PubMed ID: 3159078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mixed epidermal cell-lymphocyte reaction. II. Epidermal Langerhans cells are responsible for the enhanced allogeneic lymphocyte-stimulating capacity of normal human epidermal cell suspensions.
    Sontheimer RD
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):21s-26s. PubMed ID: 3159806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans cell induced cytotoxic T-cell responses against normal human epidermal cell targets: in vitro studies.
    Faure M; Dezutter-Dambuyant C; Schmitt D; Gaucherand M; Thivolet J
    Br J Dermatol; 1985 Jul; 113 Suppl 28():114-7. PubMed ID: 3160381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of HLA-DR and T6 antigens on keratinocytes and dendritic cells. A comparative immunohistochemical study.
    Drijkoningen M; De Wolf-Peeters C; van den Oord JJ; Degreef H; Desmet V
    Arch Pathol Lab Med; 1986 Apr; 110(4):321-5. PubMed ID: 2420303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human epidermal Langerhans cells cointernalize by receptor-mediated endocytosis "nonclassical" major histocompatibility complex class I molecules (T6 antigens) and class II molecules (HLA-DR antigens).
    Hanau D; Fabre M; Schmitt DA; Garaud JC; Pauly G; Tongio MM; Mayer S; Cazenave JP
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2901-5. PubMed ID: 3106979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoelectron microscopic identification of Langerhans cells using a new antigenic marker.
    Chu A; Eisinger M; Lee JS; Takezaki S; Kung PC; Edelson RL
    J Invest Dermatol; 1982 Feb; 78(2):177-80. PubMed ID: 7035574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defined in situ enumeration of T6 and HLA-DR expressing epidermal Langerhans cells: morphologic and methodologic aspects.
    de Jong MC; Blanken R; Nanninga J; Van Voorst Vader PC; Poppema S
    J Invest Dermatol; 1986 Dec; 87(6):698-702. PubMed ID: 2431069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of HLA-DR and OKT6 antigens on keratinocytes and dendritic cells in pemphigus.
    Picut C; Meunier J; Lee C; Lewis R
    Arch Dermatol Res; 1987; 279(8):516-20. PubMed ID: 2449139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OKT6 is not superior to HLA-DR or ATPase as a marker for Langerhans' cells in normal human epidermis.
    Liu HH; Schroeter AL; Muller SA
    Clin Exp Dermatol; 1986 May; 11(3):229-37. PubMed ID: 2943537
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen-presenting OKM5+ melanophages appear in human epidermis after ultraviolet radiation.
    Cooper KD; Neises GR; Katz SI
    J Invest Dermatol; 1986 Apr; 86(4):363-70. PubMed ID: 2943821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed skin cell-lymphocyte culture reaction (MSLR) as a model for the study of lympho-epidermal interactions.
    Czernielewski JM
    Br J Dermatol; 1985 Jul; 113 Suppl 28():17-23. PubMed ID: 3160382
    [No Abstract]   [Full Text] [Related]  

  • 17. Langerhans cells in skin from patients with psoriasis: quantitative and qualitative study of T6 and HLA-DR antigen-expressing cells and changes with aromatic retinoid administration.
    Haftek M; Faure M; Schmitt D; Thivolet J
    J Invest Dermatol; 1983 Jul; 81(1):10-4. PubMed ID: 6345681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of distinct subpopulations of Langerhans cells by flow cytometry and sorting.
    Vaigot P; Czernielewski J; Prunieras M
    Cytometry; 1985 Sep; 6(5):422-7. PubMed ID: 2931262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T6 is superior to Ia (HLA-DR) as a marker for Langerhans cells and indeterminate cells in normal epidermis: a monoclonal antibody study.
    Harrist TJ; Muhlbauer JE; Murphy GF; Mihm MC; Bhan AK
    J Invest Dermatol; 1983 Feb; 80(2):100-3. PubMed ID: 6337218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural immunogold labelling of human Langerhans cells enriched epidermal cell suspension.
    Schmitt D; Faure M; Dezutter-Dambuyant C; Tuffery D
    Arch Dermatol Res; 1984; 276(1):27-32. PubMed ID: 6367673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.